Delayed toxic effect of busulfan on the marrow
Ganda, O.P.; Mangalik, A.
Journal of the Association of Physicians of India 21(6): 511-516
1973
ISSN/ISBN: 0004-5772 PMID: 4525264 Document Number: 60920
Document emailed within 1 workday
Related Documents
Gottlieb, M.; Strober, S.; Kaplan, H.S. 1979: Allogeneic marrow transplantation after total lymphoid irradiation (TLI): effect of dose/fraction, thymic irradiation, delayed marrow infusion, and presensitization Journal of Immunology 123(1): 379-383Tutschka, P.J. 1993: Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting Bone Marrow Transplantation 12(Suppl 1): 34-36
Santos, G.W.; Tutschka, P.J. 1974: Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia Journal of the National Cancer Institute 53(6): 1781-1785
Cervantes, F.; Rozman, C.; Nomdedeu, B.; Blade, J.; Montserrat, E. 1986: Chronic myeloid leukemia: comparison of monotherapy with busulfan with busulfan and vincristine and 6-mercaptopurine cycles Revista Clinica Espanola 178(1): 4-7
Miniero, R.; Vassallo, E.; Busca, A.; Piga, A.; Perugini, L.; Madon, E. 1993: Bone marrow transplantation for children with thalassemia: two years' experience with low-dose busulfan, citoxan and GM-CSF Bone Marrow Transplantation 12(Suppl 1): 51-53
Shepherd, J.D.; Hoar, D.I.; Keown, P.A.; Phillips, G.L. 1996: Successful paternity of twins following bone marrow transplantation with busulfan, melphalan and cyclophosphamide conditioning Bone Marrow Transplantation 17(3): 461-462
Klein, J.L.; Avalos, B.R.; Belt, P.; Taylor, C.A.; Ezzone, S.A.; Scholl, M.D.; Fisher, J.; Young, D.; Copelan, E.A. 1996: Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy Bone Marrow Transplantation 17(4): 479-483
McCracken, C.H.; Lottsfeldt, J.L.; Lee, M.Y. 1988: Concurrent activation of granulocytes and osteoclasts in busulfan-suppressed bone marrow in response to transplantation of a mammary carcinoma in mice Experimental Hematology 16(4): 285-289
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661
Nagatoshi, Y.; Okamura, J.; Ikuno, Y.; Akamatsu, M.; Tasaka, H. 1997: Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children International Journal of Hematology 65(3): 269-275
Gaulier, M.; Roux, C. 1970: Effect of Busulfan on the germinal line of the rat embryo Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(11): 2165-2170
Santos, G.W.; Tutschka, P.J. 1974: Effect of busulfan on antibody production and skin allograft survival in the rat Journal of the National Cancer Institute 53(6): 1775-1780
Gottmann-Lückerath, I. 1983: Clinico-experimental study on the start of the pharmacological action of an oral classical antihistaminic without and with delayed-action effect on the length of effect of the delayed-action type Die Medizinische Welt 34(18): 548-551
Czajkowska, T.; Krysiak, B.; Popińska, E. 1987: Experimental studies of toxic effects of 1,3,5-trioxane and 1,3-dioxolane. I. Acute toxic effect Medycyna Pracy 38(3): 184-190
Czajkowska, T.; Krysiak, B. 1987: Experimental studies of the toxic effects of 1,3,5-trioxane and 1,3-dioxolane. II. Cumulation of toxic effect Medycyna Pracy 38(4): 244-249
Ruiz Maldonado, R.; Noguez Prieto, F.J. 1974: Toxic epidermal necrolysis (Lyell's syndrome) and delayed action sulfamides Boletin Medico del Hospital Infantil de Mexico 31(6): 1201-1210
Björkbom, D.M.; Brabrand, M. 2018: Delayed onset pulmonary edema following toxic smoke inhalation; a systematic review Acute Medicine 17(4): 203-211
Larrain, C.; Cruz, A.; Codoceo, V. 1984: Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases Revista Medica de Chile 112(9): 898-911
Friedman, H.Z.; Arias, A.M.; Catchatourian, R.; Fretzin, D.F. 1984: Toxic epidermal necrolysis following bone marrow transplantation Cutis 34(2): 158-162
Brandwein, J.M.; Nayar, R.; Baker, M.A.; Sutton, D.M.; Scott, J.G.; Sutcliffe, S.B.; Keating, A. 1991: GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation Experimental Hematology 19(3): 191-195